Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 2
2009 1
2010 1
2012 1
2013 3
2014 2
2015 1
2016 1
2017 2
2019 2
2020 3
2021 1
2022 10
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance.
Nantanee R, Jaru-Ampornpan P, Chantasrisawad N, Himananto O, Papakhee S, Sophonphan J, Tawan M, Jupimai T, Anugulruengkitt S, Puthanakit T; Study Team. Nantanee R, et al. Among authors: jaru ampornpan p. Vaccine X. 2023 Aug 5;15:100367. doi: 10.1016/j.jvacx.2023.100367. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37601322 Free PMC article.
Self-enhancement lateral flow immunoassay for COVID-19 diagnosis.
Ruantip S, Pimpitak U, Rengpipat S, Pasomsub E, Seepiban C, Gajanandana O, Torvorapanit P, Hirankarn N, Jaru-Ampornpan P, Siwamogsatham S, Pongpaibool P, Siwamogsatham S, Thongchul N, Chaiyo S. Ruantip S, et al. Among authors: jaru ampornpan p. Sens Actuators B Chem. 2023 Aug 15;389:133898. doi: 10.1016/j.snb.2023.133898. Epub 2023 Apr 29. Sens Actuators B Chem. 2023. PMID: 37151731 Free PMC article.
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.
Tangsathapornpong A, Nanthapisal S, Pontan K, Bunjoungmanee P, Neamkul Y, Boonyarangkul A, Wanpen S, Fukpho W, Jitpokasem S, Tharabenjasin P, Jaru-Ampornpan P. Tangsathapornpong A, et al. Among authors: jaru ampornpan p. Vaccines (Basel). 2023 Feb 27;11(3):553. doi: 10.3390/vaccines11030553. Vaccines (Basel). 2023. PMID: 36992137 Free PMC article.
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.
Chantasrisawad N, Techasaensiri C, Kosalaraksa P, Phongsamart W, Tangsathapornpong A, Jaru-Ampornpan P, Sophonphan J, Suntarattiwong P, Puthanakit T; KIDSVAX study team. Chantasrisawad N, et al. Among authors: jaru ampornpan p. Int J Infect Dis. 2023 May;130:52-59. doi: 10.1016/j.ijid.2023.02.017. Epub 2023 Feb 24. Int J Infect Dis. 2023. PMID: 36841501 Free PMC article. Clinical Trial.
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster.
Chantasrisawad N, Puthanakit T, Kornsitthikul K, Jaru-Ampornpan P, Tawan M, Matapituk P, Sophonphan J, Anugulruengkitt S, Tangsathapornpong A, Katanyutanon A; KIDSBOOST study team*. Chantasrisawad N, et al. Among authors: jaru ampornpan p. Vaccine X. 2022 Sep 30;12:100221. doi: 10.1016/j.jvacx.2022.100221. eCollection 2022 Dec. Vaccine X. 2022. PMID: 36213592 Free PMC article.
33 results